- Home
- DETX vs DYAI Comparison
DETX vs DYAI Comparison
Compare DETX & DYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DETX | DYAI |
|---|---|---|
| Founded | N/A | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.8M | 17.0M |
| IPO Year | 2022 | 2026 |
Fundamental Metrics
Financial Performance| Metric | DETX | DYAI |
|---|---|---|
| Price | $2.14 | $0.49 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $3.00 |
| AVG Volume (30 Days) | 33.6K | ★ 206.5K |
| Earning Date | N/A | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $3,090,345.00 |
| Revenue This Year | N/A | $122.79 |
| Revenue Next Year | N/A | $100.00 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.91 | $0.34 |
| 52 Week High | $4.25 | $1.60 |
Technical Indicators
Market Signals| Indicator | DETX | DYAI |
|---|---|---|
| Relative Strength Index (RSI) | 36.75 | 39.67 |
| Support Level | $1.97 | $0.34 |
| Resistance Level | $2.43 | $0.87 |
| Average True Range (ATR) | 0.24 | 0.06 |
| MACD | 0.02 | 0.02 |
| Stochastic Oscillator | 38.78 | 71.59 |
Price Performance
Historical ComparisonAbout DETX Liberty Defense Holdings Ltd. Common Shares
Liberty Defense Holdings Ltd is engaged in the development and commercialization of security detection technologies such as airports, stadiums, schools, and more. The company's Hexwave product utilizes millimeter wave technology and Advanced 3D imaging to detect concealed threats. In addition to HEXWAVE, the company has licensed High-Definition Advanced Imaging Technology (HD-AIT) for body and shoe scanning. The Company operates through three distinct segments: Corporate, HEXWAVE, and Contract. The company generates the majority of its revenue from the Contract segment. Geographically, the company generates the majority of its revenue from the United States.
About DYAI Dyadic International Inc.
Dyadic International Inc is a biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.